InsidersTradesSigma
에이프로젠 Stock: price and management transactions · South Korea · DART (FSS)
Follow the 에이프로젠 stock price and the full management transaction log of the company, a listed issuer based in South Korea. Shares are listed on KR KR, under the authority of DART (FSS). Operating in the Industrials sector, 에이프로젠 has published 146 public disclosures. Market capitalisation: €52.3bn. The latest transaction was filed on 1 July 2026 (Other). Among the most active insiders: 지베이스. Every trade is openly available.
146
Insider Decl.
0
Thresholds
€53m
4 ops.
Buy Volume
€754m
64 ops.
Sell Volume
22Σ signal
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Fundamental score
Ranked 25,137 of 25,567 companies
8.8
score / 100
Value1
Quality17
FCF yld-133%
Earn yld-144%
EV/EBITDA·
ROE-33%
Gross mgn28%
Net mgn-60%
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
Last declaration on 1 July 2026
Declarations146 total
25 of 146 declarations
About 에이프로젠
Aprogen is a company operating in the industrial sector, listed on the XKRX. It focuses on the development and production of biopharmaceutical products.